BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37685922)

  • 21. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ.
    Clerc I; Polakowski N; André-Arpin C; Cook P; Barbeau B; Mesnard JM; Lemasson I
    J Biol Chem; 2008 Aug; 283(35):23903-13. PubMed ID: 18599479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.
    Macaire H; Riquet A; Moncollin V; Biémont-Trescol MC; Duc Dodon M; Hermine O; Debaud AL; Mahieux R; Mesnard JM; Pierre M; Gazzolo L; Bonnefoy N; Valentin H
    J Biol Chem; 2012 Jun; 287(25):21357-70. PubMed ID: 22553204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.
    Giam CZ; Semmes OJ
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27322308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.
    Jain P; Lavorgna A; Sehgal M; Gao L; Ginwala R; Sagar D; Harhaj EW; Khan ZK
    Retrovirology; 2015 Feb; 12():23. PubMed ID: 25809782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription.
    Tang HM; Gao WW; Chan CP; Cheng Y; Deng JJ; Yuen KS; Iha H; Jin DY
    J Virol; 2015 Aug; 89(16):8623-31. PubMed ID: 26063426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription.
    Ku SC; Lee J; Lau J; Gurumurthy M; Ng R; Lwa SH; Lee J; Klase Z; Kashanchi F; Chao SH
    J Virol; 2008 May; 82(9):4343-53. PubMed ID: 18287238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV-1 Alters T Cells for Viral Persistence and Transmission.
    Tanaka A; Matsuoka M
    Front Microbiol; 2018; 9():461. PubMed ID: 29615995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.
    Hagiya K; Yasunaga J; Satou Y; Ohshima K; Matsuoka M
    Retrovirology; 2011 Mar; 8():19. PubMed ID: 21414204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of caspase 9 in activation of HTLV-1 LTR expression by DNA damaging agents.
    Abou-Kandil A; Chamias R; Huleihel M; Godbey WT; Aboud M
    Cell Cycle; 2011 Oct; 10(19):3337-45. PubMed ID: 21957492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.
    Cavanagh MH; Landry S; Audet B; Arpin-André C; Hivin P; Paré ME; Thête J; Wattel E; Marriott SJ; Mesnard JM; Barbeau B
    Retrovirology; 2006 Mar; 3():15. PubMed ID: 16512901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo antagonistic role of the Human T-Cell Leukemia Virus Type 1 regulatory proteins Tax and HBZ.
    Akkouche A; Moodad S; Hleihel R; Skayneh H; Chambeyron S; El Hajj H; Bazarbachi A
    PLoS Pathog; 2021 Jan; 17(1):e1009219. PubMed ID: 33471856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.
    Panfil AR; Dissinger NJ; Howard CM; Murphy BM; Landes K; Fernandez SA; Green PL
    J Virol; 2016 Jan; 90(7):3760-72. PubMed ID: 26819304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
    Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
    Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription regulatory complexes bind the human T-cell leukemia virus 5' and 3' long terminal repeats to control gene expression.
    Lemasson I; Polakowski NJ; Laybourn PJ; Nyborg JK
    Mol Cell Biol; 2004 Jul; 24(14):6117-26. PubMed ID: 15226416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
    Matsuoka M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.
    Song X; Qu Z
    PLoS One; 2024; 19(5):e0303138. PubMed ID: 38722890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-1 basic leucine zipper factor protects cells from oxidative stress by upregulating expression of Heme Oxygenase I.
    Rushing AW; Rushing B; Hoang K; Sanders SV; Péloponèse JM; Polakowski N; Lemasson I
    PLoS Pathog; 2019 Jun; 15(6):e1007922. PubMed ID: 31251786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
    Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
    Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing.
    Shallak M; Alberio T; Fasano M; Monti M; Iacobucci I; Ladet J; Mortreux F; Accolla RS; Forlani G
    Front Immunol; 2022; 13():939863. PubMed ID: 35979358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.